Summary

U.S. Veterinary Clinical Chemistry Diagnostics Market Summary

The U.S. veterinary clinical chemistry diagnostics market size was estimated at USD 764.05 million in 2024 and is projected to reach USD 1,405.32 million by 2033, growing at a CAGR of 7.19% from 2025 to 2033. The industry is primarily driven by increasing focus on preventive and wellness testing, expansion of veterinary practices and specialty clinics, and advancements in diagnostic technology and point-of-care testing. Modern veterinary practice is focused on preventive care, emphasizing wellness screening at all life stages of animals. The veterinarian visits for preventive care of pet owners are 1.5 times for dogs and 0.7 times for cats in the U.S. annually. This improvement reflects regular veterinary visits, preventive care, and growing investment in animal health.

Veterinarians can monitor organ function, identify subclinical diseases, and set baselines for long-term health management via clinical chemistry tests. Pre-anesthetic examinations, geriatric pet care, and yearly checkups are all increasingly promoting routine wellness testing. In addition, more people are getting pet insurance, which makes it easier for owners to have preventive diagnostics. This proactive approach improves animal health outcomes and ensures sustained demand for chemistry analyzers, reagents, and laboratory services in the veterinary sector.

The steady growth of veterinary practices, specialty clinics, and corporate veterinary chains across the U.S. is driving demand for clinical chemistry diagnostics. With more multi-specialty animal hospitals and referral centers, the need for rapid, reliable diagnostic capabilities is increasing. These facilities require in-house analyzers to support routine screenings, pre-surgical evaluations, and management of critical care patients. Large chains' consolidation of veterinary services boosts the widespread use of innovative diagnostic tools, guaranteeing consistency in treatment. This expansion increases testing volumes, improves diagnostic accessibility, and further incorporates clinical chemistry into global standard veterinary care pathways.

The U.S. veterinary clinical chemistry diagnostics industry is expanding due to rapid technology improvements. Veterinarians may now perform tests in-clinic more quickly and accurately because of innovations including enhanced reagents, fully automated benchtop systems, and small point-of-care analyzers. These technologies reduce turnaround time, improve diagnostic precision, and allow immediate treatment decisions. Integration of digital platforms and connectivity with veterinary practice management systems further enhances workflow efficiency. Portable and user-friendly systems are especially attractive to small and mid-sized practices. This shift toward real-time, in-practice diagnostics reduces reliance on external laboratories, boosting accessibility and driving widespread adoption among veterinarians.

U.S. Veterinary Clinical Chemistry Diagnostics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. veterinary clinical chemistry diagnostics market report based on product, animal, test, sample, and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables, Reagents & Kits
• Equipment & Instruments
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Companion Animals
o Dogs
o Cats
o Horses
o Other Companion Animals
• Production Animals
o Cattle
o Poultry
o Swine
o Other Production Animals
• Test Outlook (Revenue, USD Million, 2021 - 2033)
• Renal Function Test (RFT)
• Liver Function Test (LFT)
• Electrolyte Panel
• Other Tests
• Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
• Blood/Plasma/Serum
• Urine
• Other Samples
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Reference Laboratories
• Veterinarians
• Animal Owners/ Producers

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information/Data Analysis
1.6. Market Formulation & Visualization
1.7. Data Validation & Publishing
1.8. Model Details
1.8.1. Commodity flow analysis
1.8.2. Bottom Up Approach
1.8.3. Multivariate Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Veterinary Clinical Chemistry Diagnostics Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Focus on Preventive and Wellness Testing
3.2.1.2. Expansion of Veterinary Practices and Specialty Clinics
3.2.1.3. Advancements in Diagnostic Technology and Point-Of-Care Testing
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent Regulatory Compliance and Approval Processes
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL by SWOT Analysis
3.4. Pricing Analysis
3.5. Regulatory Landscape
3.6. Technology Landscape
3.7. Estimated Animal Population by Key Species, 2021 - 2024
Chapter 4. U.S. Veterinary Clinical Chemistry Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Veterinary Clinical Chemistry Diagnostics Market: Product Movement Analysis
4.3. U.S. Veterinary Clinical Chemistry Diagnostics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Consumables, Reagents & Kits
4.4.1. Consumables, Reagents & Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Equipment & Instruments
4.5.1. Equipment & Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Veterinary Clinical Chemistry Diagnostics Market: Animal Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Veterinary Clinical Chemistry Diagnostics Market: Animal Movement Analysis
5.3. U.S. Veterinary Clinical Chemistry Diagnostics Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
5.4. Companion Animals
5.4.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. Dogs
5.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Cats
5.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.4. Horses
5.4.4.1. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.5. Other companion animals
5.4.5.1. Other companion animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Production Animals
5.5.1. Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Cattle
5.5.2.1. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Poultry
5.5.3.1. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. Swine
5.5.4.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.5. Other production animals
5.5.5.1. Other production animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Veterinary Clinical Chemistry Diagnostics Market: Test Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Veterinary Clinical Chemistry Diagnostics Market: Test Movement Analysis
6.3. U.S. Veterinary Clinical Chemistry Diagnostics Market Size & Trend Analysis, by Test, 2021 to 2033 (USD Million)
6.4. Renal Function Test (RFT)
6.4.1. Renal Function Test (RFT) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Liver Function Test (LFT)
6.5.1. Liver Function Test (LFT) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Electrolyte Panel
6.6.1. Electrolyte Panel Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Others
6.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Veterinary Clinical Chemistry Diagnostics Market: Sample Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Veterinary Clinical Chemistry Diagnostics Market: Sample Movement Analysis
7.3. U.S. Veterinary Clinical Chemistry Diagnostics Market Size & Trend Analysis, by Sample, 2021 to 2033 (USD Million)
7.4. Blood/Plasma/Serum
7.4.1. Blood/Plasma/Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Urine
7.5.1. Urine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Veterinary Clinical Chemistry Diagnostics Market: By End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. U.S. Veterinary Clinical Chemistry Diagnostics Market: By End Use Movement Analysis
8.3. U.S. Veterinary Clinical Chemistry Diagnostics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.3.1. Reference Laboratories
8.3.1.1. Reference Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. Veterinarians
8.3.2.1. Veterinarians Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3. Animal Owners/ Producers
8.3.3.1. Animal Owners/ Producers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Company Market Position Analysis/ Heat Map Analysis
9.3. Company Profiles
9.3.1. IDEXX Laboratories, Inc.
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product/ Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Zoetis
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product/ Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Antech Diagnostics, Inc. (Mars Inc.)
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product/ Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Heska Corporation
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product/ Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Beckman Coulter
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product/ Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Siemens Healthineers AG
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product/ Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Randox Laboratories
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product/ Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Skyla Corporation
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product/ Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Woodley Equipment Company Ltd
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product/ Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. ARKRAY, Inc
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product/ Service Benchmarking
9.3.10.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Product/ Service launch
9.4.4. Others
9.5. List of other key players